Position in PCVX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$11,781,380
+$4,100,517 QoQ
Shares Held
202,673
+53.3% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Jun 30, 2025CallValue
$972,049
CallShares
29,900
PutValue
$972,049
PutShares
29,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. PCVX ranks #33 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in PCVX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,781,380 | 202,673 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $7,680,863 | 132,178 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $11,160,342 | 241,880 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,277,068 | 313,078 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $13,956,021 | 429,284 | Shares | Defined | 2025-08-11 | |
| 2025-06-30 | $972,049 | 29,900 | Put | Defined | 2025-08-11 | |
| 2025-06-30 | $972,049 | 29,900 | Call | Defined | 2025-08-11 | |
| 2025-03-31 | $23,451,940 | 621,079 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,023,250 | 12,500 | Put | Defined | 2025-02-12 | |
| 2024-12-31 | $1,023,250 | 12,500 | Call | Defined | 2025-02-12 | |
| 2024-12-31 | $31,041,965 | 379,208 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $25,201,447 | 220,543 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $12,519,179 | 165,795 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $9,895,864 | 144,867 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,955,673 | 78,912 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,865,479 | 95,439 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $3,926,431 | 78,623 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $5,550,262 | 148,086 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $297,290 | 6,200 | Call | Defined | 2023-02-09 | |
| 2022-12-31 | $5,694,829 | 118,766 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $148,800 | 6,200 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $3,730,536 | 155,439 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,219,995 | 56,066 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $298,976 | 12,380 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,104,641 | 46,433 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $641,201 | 25,274 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,913,687 | 85,015 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $2,238,188 | 113,326 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $140,023 | 5,270 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $43,158 | 874 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||